US Stock MarketDetailed Quotes

HOLX Hologic

Watchlist
  • 54.160
  • -3.120-5.45%
Close May 2 16:00 ET
  • 54.160
  • 0.0000.00%
Post 20:01 ET
12.07BMarket Cap22.76P/E (TTM)

About Hologic Company

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Company Profile

SymbolHOLX
Company NameHologic
Listing DateMar 2, 1990
Issue Price14.00
Founded1985
CEOMr. Stephen P. Macmillan
MarketNASDAQ
Employees7063
Fiscal Year Ends09-27
Address250 Campus Drive
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-263-2900

Company Executives

  • Name
  • Position
  • Salary
  • Stephen P. Macmillan
  • Chairman of the Board, Chief Executive Officer and President
  • 15.82M
  • Karleen M. Oberton
  • Chief Financial Officer
  • 4.09M
  • Essex D. Mitchell
  • Chief Operating Officer
  • 4.08M
  • Benjamin J. Cohn
  • Vice President, Corporate Controller and Principal Accounting Officer
  • --
  • Diana De Walt
  • Senior Vice President, Human Resources
  • --
  • Jennifer Schneiders
  • President, Diagnostics Solutions
  • --
  • Mark Horvath
  • Division President, Breast and Skeletal Health Solutions
  • --
  • Jan Verstreken
  • Group President, International
  • 3.59M
  • Brandon Schnittker
  • Division President, GYN Surgical Solutions
  • --
  • Dr. Martin D. Madaus,PhD
  • Director
  • --
  • Wayde D. McMillan
  • Director
  • --
  • Sally Wellinghoff Crawford
  • Independent Director
  • 357.45K
  • Scott T. Garrett
  • Independent Director
  • 349.95K
  • Stacey D. Stewart
  • Independent Director
  • 329.95K
  • Nanaz Mohtashami
  • Independent Director
  • 329.95K
  • Christiana Stamoulis, M.B.A.
  • Independent Director
  • 329.95K
  • Amy A. Wendell
  • Lead Independent Director
  • 357.45K
  • Charles J. Dockendorff
  • Independent Director
  • 354.95K
  • Dr. Ludwig N. Hantson, PhD
  • Independent Director
  • 329.95K

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More